Taiwan FDA registration 060e759358db7bc1c2c51d6e065d524e
"Melody" extravasation detection system
TW: “美樂得”外滲偵測系統
Taiwan·Risk Class 2·Bayer Medical Care Inc.·Registered Mar 01, 2010 – Mar 01, 2020CancelledRegistration details
- Analysis ID
- 060e759358db7bc1c2c51d6e065d524e
- Customs Code
- DHA00602083500
Company information
- Manufacturer
- Bayer Medical Care Inc.
- Manufacturer Country
- United States
- Authorized Representative
- HSIEN TAI INSTRUMENTS CO., LTD.
Product details
- Intended Use
- The MEDRAD extravasation detection system (XDS) can be used to help detect the presence of intravenous contrast agent infiltrating into surrounding tissues from the injection site during a patient's diagnostic examination with computed tomography (CT).
- Product Type (Level 1)
- E Cardiovascular Medicine Science
- Import Information
- import
Dates and status
- Registration Date
- Mar 01, 2010
- Expiry Date
- Mar 01, 2020
- Cancellation Date
- May 19, 2022
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for "Melody" extravasation detection system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 060e759358db7bc1c2c51d6e065d524e and manufactured by Bayer Medical Care Inc.. The authorized representative in Taiwan is HSIEN TAI INSTRUMENTS CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices